Zacks Research Upgrades Oxbridge Re (NASDAQ:OXBR) to “Hold”

Oxbridge Re (NASDAQ:OXBR) was upgraded by equities researchers at Zacks Research to a “hold” rating in a research report issued on Wednesday,Zacks.com reports.

A number of other research analysts have also recently weighed in on the stock. Maxim Group cut their price objective on shares of Oxbridge Re from $5.00 to $3.00 and set a “buy” rating on the stock in a research report on Tuesday. Weiss Ratings lowered shares of Oxbridge Re from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, June 3rd. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Oxbridge Re has an average rating of “Hold” and an average target price of $3.00.

Oxbridge Re Price Performance

NASDAQ:OXBR opened at $0.95 on Wednesday. The firm has a market capitalization of $7.73 million, a price-to-earnings ratio of -3.82 and a beta of 2.02. The company has a debt-to-equity ratio of 0.16, a current ratio of 8.15 and a quick ratio of 8.15. The business has a 50 day simple moving average of $0.91 and a 200-day simple moving average of $1.05. Oxbridge Re has a 1 year low of $0.66 and a 1 year high of $2.86.

Oxbridge Re (NASDAQ:OXBR) last released its earnings results on Saturday, February 14th. The insurance provider reported $0.02 earnings per share for the quarter. Oxbridge Re had a negative return on equity of 33.33% and a negative net margin of 76.47%.The firm had revenue of $0.58 million for the quarter. Equities analysts forecast that Oxbridge Re will post -0.04 EPS for the current year.

Institutional Trading of Oxbridge Re

A number of large investors have recently made changes to their positions in the stock. Virtu Financial LLC bought a new position in shares of Oxbridge Re in the third quarter worth about $32,000. Henrickson Nauta Wealth Advisors Inc. lifted its holdings in Oxbridge Re by 100.0% during the 4th quarter. Henrickson Nauta Wealth Advisors Inc. now owns 137,400 shares of the insurance provider’s stock valued at $185,000 after buying an additional 68,700 shares in the last quarter. International Assets Investment Management LLC purchased a new stake in Oxbridge Re in the 4th quarter valued at about $39,000. Finally, J.W. Cole Advisors Inc. boosted its position in Oxbridge Re by 106.1% in the 4th quarter. J.W. Cole Advisors Inc. now owns 68,000 shares of the insurance provider’s stock valued at $90,000 after buying an additional 35,000 shares during the period. 5.64% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about Oxbridge Re

Here are the key news stories impacting Oxbridge Re this week:

• Positive Sentiment: SurancePlus reported annualized returns of 29.3% and 43.4% on its tokenized reinsurance offerings, exceeding original target returns and potentially validating Oxbridge Re’s RWA platform. Article Title
• Positive Sentiment: Maxim Group reiterated a Buy rating and $3.00 price target, while forecasting profitability improvement in several upcoming quarters, which signals optimism about Oxbridge Re’s earnings outlook.
• Neutral Sentiment: Zacks Research upgraded Oxbridge Re to Hold, a modestly supportive but not strongly bullish rating change. Article Title
• Neutral Sentiment: Maxim Group’s estimates still point to a choppy earnings path, with several quarters expected to be negative and FY2026/FY2027 projected to remain in the red, suggesting the turnaround is not yet complete.
• Negative Sentiment: Oxbridge Re’s recent earnings history remains weak, with a negative return on equity and negative net margin, which may continue to limit investor confidence in the near term.

About Oxbridge Re

Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.

The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.